Pembrolizumab With Nab-Paclitaxel in Non-Small Cell Lung Cancer
Clinical trial NCT02733250 · COMPLETED
Trial details
- NCT number
- NCT02733250
- Sponsor
- Centre hospitalier de l'Université de Montréal (CHUM)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-13
- Primary completion
- 2019-04-13
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.